Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7049007 | 0.71 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2ALOX15 | |
| SCHEMBL28443985 | 0.68 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2ALOX15 | |
| SCHEMBL1374565 | 0.66 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2ALOX15 | |
| SCHEMBL28449449 | 0.65 | CYP1A2 (0.41) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL29022393 | 0.65 | ALOX15 (0.41) | ALOX15 | |
| SCHEMBL7559333 | 0.65 | — | — | |
| SCHEMBL11317 | 0.65 | — | — | |
| Hydrochloric Acid SCHEMBL3806550 | 0.64 | — | — | |
| SCHEMBL6159345 | 0.64 | — | — | |
| Ammonia Solution, Strong SCHEMBL8665541 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-62059295-A | — | — | None | — | — | JP | disclosed |
| JP-62084099-A | — | — | None | — | — | JP | disclosed |
| JP-55062073-A | — | — | None | — | — | JP | disclosed |
| JP-8245762-A | — | — | None | — | — | JP | disclosed |
| EP-3786151-B1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-20210147473-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2021-05-20 | — | — | US | disclosed |
| EP-3786151-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | Chubu University Educational Foundation (JP) | 2021-03-03 | — | — | EP | disclosed |
| CN-112020492-A | Process for producing amide compound | 学校法人中部大学 | 2020-12-01 | — | — | CN | disclosed |
| US-10358526-B2 | Moisture-curing polyether carbonate containing alkoxysilyl groups | COVESTRO DEUTSCHLAND AG (DE) | 2019-07-23 | — | — | US | disclosed |
| US-20170313816-A1 | MOISTURE-CURING POLYETHER CARBONATE CONTAINING ALKOXYSILYL GROUPS | COVESTRO DEUTSCHLAND AG (DE) | 2017-11-02 | — | — | US | disclosed |
| EP-0527069-A1 | Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them | Aventis Pharma S.A. (FR) | 1993-02-10 | — | — | EP | disclosed |
| WO-1993001167-A1 | PYRROLIDINE AND THIAZOLIDINE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1993-01-21 | — | — | WO | disclosed |
| US-5145846-A | Skin disorders, leukemia, sebaceous gland disorders | HOFFMANN-LA ROCHE INC. (US) | 1992-09-08 | — | — | US | disclosed |
| US-5087619-A | For treatment of skin or gland disorders; antitumor agents | HOFFMAN-LA ROCHE INC. (US) | 1992-02-11 | — | — | US | disclosed |
| EP-0382935-A1 | 2-(1H-imidazol-4(5)-yl)-3,4-dihydro-2H-1-benzothiopyran | FARMITALIA CARLO ERBA S.r.l. (IT) | 1990-08-22 | — | — | EP | disclosed |
| JP-S6284099-A | NOVEL PRODUCTION OF PEPTIDE | SUNTORY LTD | 1987-04-17 | — | — | JP | disclosed |
| JP-S6259295-A | NOVEL PROCESS FOR PRODUCING PEPTIDE | SUNTORY LTD | 1987-03-14 | — | — | JP | disclosed |
| JP-S5562073-A | PRODUCTION OF IMIDAZOLE | SUMITOMO CHEM CO LTD | 1980-05-10 | — | — | JP | disclosed |
| JP-S06259295-A | — | — | 0001-01-01 | — | — | JP | disclosed |
| JP-S06284099-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147473-A1 | METHOD FOR PRODUCING AMIDE COMPOUND | ASNS, VIP, BCAT2 | ALDH1A1 2505/4885SMN1; SMN2 2484/4885ALOX15 2610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.